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Badrov MB, Lalande S, Olver TD, Suskin N, Shoemaker JK.
Effects of aging and coronary artery disease on sympathetic neural
recruitment strategies during end-inspiratory and end-expiratory apnea. Am J Physiol Heart Circ Physiol 311: H1040 –H1050, 2016. First
published August 19, 2016; doi:10.1152/ajpheart.00334.2016.—In
response to acute physiological stress, the sympathetic nervous system
modifies neural outflow through increased firing frequency of lowerthreshold axons, recruitment of latent subpopulations of higherthreshold axons, and/or acute modifications of synaptic delays. Aging
and coronary artery disease (CAD) often modify efferent muscle
sympathetic nerve activity (MSNA). Therefore, we investigated
whether CAD (n ⫽ 14; 61 ⫾ 10 yr) and/or healthy aging without
CAD (OH; n ⫽ 14; 59 ⫾ 9 yr) modified these recruitment strategies
that normally are observed in young healthy (YH; n ⫽ 14; 25 ⫾ 3 yr)
individuals. MSNA (microneurography) was measured at baseline and
during maximal voluntary end-inspiratory (EI) and end-expiratory
(EE) apneas. Action potential (AP) patterns were studied using a
novel AP analysis technique. AP frequency increased in all groups
during both EI- and EE-apnea (all P ⬍ 0.05). The mean AP content
per integrated burst increased during EI- and EE-apnea in YH (EI:
⌬6 ⫾ 4 APs/burst; EE: ⌬10 ⫾ 6 APs/burst; both P ⬍ 0.01) and OH
(EI: ⌬3 ⫾ 3 APs/burst; EE: ⌬4 ⫾ 5 APs/burst; both P ⬍ 0.01), but not
in CAD (EI: ⌬1 ⫾ 3 APs/burst; EE: ⌬2 ⫾ 3 APs/burst; both P ⫽ NS).
When APs were binned into “clusters” according to peak-to-peak
amplitude, total clusters increased during EI- and EE-apnea in YH
(EI: ⌬5 ⫾ 2; EE: ⌬6 ⫾ 4; both P ⬍ 0.01), during EI-apnea only in OH
(EI: ⌬1 ⫾ 2; P ⬍ 0.01; EE: ⌬1 ⫾ 2; P ⫽ NS), and neither apnea in
CAD (EI: ⌬ ⫺2 ⫾ 2; EE: ⌬ ⫺1 ⫾ 2; both P ⫽ NS). In all groups, the
AP cluster size-latency profile was shifted downwards for every
corresponding cluster during EI- and EE-apnea (all P ⬍ 0.01). As
such, inherent dysregulation exists within the central features of
apnea-related sympathetic outflow in aging and CAD.
coronary artery disease; sympathetic nervous system; aging; sympathetic neural recruitment patterns; apnea

NEW & NOTEWORTHY

The current data provide the first multiunit evidence that the
sympathetic dysregulation observed under resting conditions
with increasing age and cardiovascular disease extends to the
neural recruitment strategies employed by the sympathetic
nervous system in response to an acute homeostatic challenge.

dysregulation represents a hallmark of increasing age and cardiovascular disease. This dysregulation has been well-studied at rest, where aging and
cardiovascular disease are characterized by a net elevation in
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baseline sympathetic outflow (14, 35), which contributes to
numerous deleterious consequences, including cardiac and vascular damage and remodeling, cardiac dysrhythmias, and an
elevated risk of mortality (4, 13, 29). However, the mechanisms involved in aberrant sympathetic control with aging and
cardiovascular disease, such as the distinct features of central
recruitment strategies, are not known.
Normally, sympathetic neural control involves central integration of sensory and cortical/subcortical signals within the
brain stem and spinal cord (3), synapses at the sympathetic
ganglia (18), efferent postganglionic nerve traffic, neurotransmitter release, and the subsequent vascular effect at the end
organ (36). These elements introduce multiple sites of control
in which sympathetic outflow can be coded and modified in
response to acute physiological perturbation. Data from direct
single- and multifiber recordings of central sympathetic outflow in young healthy individuals indicate that the sympathetic
nervous system has options to increase the firing frequency and
probability of low-threshold axons (22, 31), recruit latent
subpopulations of higher-threshold and faster conducting axons (2, 39), as well as acutely modify synaptic delays and/or
central processing times (2, 32). These patterns illustrate
unique properties of the central nervous system to fine-tune
autonomic homeostatic control.
Whether these neural coding strategies are affected by increasing age and cardiovascular pathology normally associated
with advancing age remains uncertain. While recordings from
single muscle vasoconstrictor axons reveal an increased firing
probability and frequency of single units in cardiovascular
disease (15, 21), the typical observation that a given neuron
will fire usually only once per sympathetic burst at rest appears
unchanged in congestive heart failure with reduced left ventricular ejection fraction (LVEF) (21, 23). Conversely, withinburst firing frequency of single axons at baseline is increased in
other states of chronic sympathetic arousal, such as obstructive
sleep apnea (10) and chronic obstructive pulmonary disease
(1), as well as in response to an acute physiological challenge
(9, 22, 27). However, information regarding the several recruitment strategies available (i.e., recruitment of new axons) to the
sympathetic nervous system cannot be extracted from singleunit recordings, but requires a multiunit analysis model. Using
multifiber recordings, we have documented recruitment of
new subpopulations of larger axons (2, 5, 39), as well as
modifiable synaptic delays (2), in response to voluntary
apnea-induced sympathoexcitation in young healthy individuals. However, the ability to recruit latent neuronal
subpopulations may be diminished with healthy aging and
cardiovascular disease (24, 25).
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Therefore, the current study examined the hypothesis that
cardiovascular disease impairs sympathetic neural recruitment.
Coronary artery disease (CAD) patients with preserved LVEF
completed maximal voluntary apneas, which served as a stimulus for sympathoexcitation, and the response was compared
with that of young healthy and older healthy individuals to
account for the concurrent effect of age.
METHODS

Participants. Forty-two individuals participated in the current investigation after providing informed written consent. Participants
comprised three groups: 1) young healthy individuals (YH; n ⫽ 14, 5
females), 2) older healthy individuals (OH; n ⫽ 14; 6 females), and 3)
CAD patients (CAD; n ⫽ 14, 3 females). Participant characteristics
are summarized in Table 1. YH and OH participants were nonsmokers, free of overt disease, and nonmedicated. CAD patients included
those who were discharged from hospital following an acute ST
elevation (n ⫽ 7) or non-ST elevation (n ⫽ 7) myocardial infarction
(MI) as documented by their attending physician. In all instances,
patients presented with their first MI. Eleven patients underwent
percutaneous coronary intervention and four underwent coronary
artery bypass grafting surgery. No CAD patients had a history of
congestive heart failure, renal insufficiency, or diabetes mellitus, and
all had preserved LVEF at the time of study. Although all patients
were on antihypertensive medications, all presented with resting blood
pressures within the normal range (i.e., ⬍140/90 mmHg). Six patients
were former or current smokers at the time of study. On average,
testing took place 67 ⫾ 37 days following hospital discharge. Medication use in the CAD patients included beta-blockers (n ⫽ 13; 93%),
angiotensin converting enzyme inhibitors (n ⫽ 13; 93%), calcium
channel blockers (n ⫽ 3; 21%), diuretics (n ⫽ 1; 8%), statins (n ⫽ 13;
93%), and anti-platelets, including aspirin (n ⫽ 14; 100%). All
experimental protocols were approved by the Health Sciences Research Ethics Board at Western University.
Experimental protocols. Participants arrived for testing having
fasted and abstained from caffeine and alcohol for 12 h, and vigorous

Table 1. Participant characteristics
Age, yr
Height, cm
Weight, kg
Body mass index, kg/m2
Systolic BP, mmHg
Diastolic BP, mmHg
HR, beats/min
CO, l/min
TPR, mmHg·l⫺1·min
LVEF, %
Burst frequency, bursts/min
Burst incidence, bursts/100 hb
Total MSNA, AU
Glucose, mmol/l
Total cholesterol, mmol/l
HDL cholesterol, mmol/l
LDL cholesterol, mmol/l
Triglycerides, mmol/l
HbA1C, %

YH

OH

CAD

25 ⫾ 3
173 ⫾ 8
74 ⫾ 13
25 ⫾ 4
113 ⫾ 13
69 ⫾ 10
63 ⫾ 6
6.2 ⫾ 1.3
14 ⫾ 4
68 ⫾ 4
18 ⫾ 8
29 ⫾ 13
989 ⫾ 380
5.1 ⫾ 0.6
3.6 ⫾ 1.0
1.2 ⫾ 0.2
2.0 ⫾ 1.0
0.9 ⫾ 0.3
5.4 ⫾ 0.2

59 ⫾ 9*
168 ⫾ 7
68 ⫾ 11
25 ⫾ 2
121 ⫾ 16
74 ⫾ 10
58 ⫾ 8
5.4 ⫾ 1.4
18 ⫾ 7
68 ⫾ 4
34 ⫾ 9*
58 ⫾ 14*
1,916 ⫾ 540*
5.2 ⫾ 0.4
4.3 ⫾ 0.6
1.5 ⫾ 0.3
2.4 ⫾ 0.6
0.9 ⫾ 0.4
5.7 ⫾ 0.2*

61 ⫾ 10*
169 ⫾ 9
86 ⫾ 15*†
30 ⫾ 5*†
120 ⫾ 21
66 ⫾ 9
60 ⫾ 8
6.2 ⫾ 1.2
14 ⫾ 4
61 ⫾ 9
41 ⫾ 7*
69 ⫾ 11*
2,331 ⫾ 372*
5.6 ⫾ 0.7
3.2 ⫾ 0.6†
1.0 ⫾ 0.1†
1.7 ⫾ 0.5
1.0 ⫾ 0.3
5.8 ⫾ 0.3*

Values are the mean of the two baseline periods (mean ⫾ SD). YH, young
healthy; OH, older healthy; CAD, coronary artery disease; BP, blood pressure;
HR, heart rate; CO, cardiac output; TPR, total peripheral resistance; LVEF, left
ventricular ejection fraction; hb, heart beats; MSNA, muscle sympathetic nerve
activity; AU, arbitrary units. HDL, high-density lipoprotein; LDL, low-density
lipoprotein; HbA1C, hemoglobin A1C. *Significantly different from YH, P ⬍
0.01; †Significantly different from OH, P ⬍ 0.01.
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exercise for 24 h. Data were collected in the supine position during 1)
a 1-min baseline period and a subsequent end-inspiratory (EI) apnea
of maximal voluntary duration, and 2) a 1-min baseline period and a
subsequent end-expiratory (EE) apnea of maximal voluntary duration.
Both EI- and EE-apnea were repeated twice, with each trial separated
by 3 min of rest. EI- and EE-apnea were used as stimuli to increase
muscle sympathetic nerve activity (MSNA) in order to study the
neural recruitment strategies employed by the sympathetic nervous
system during reflex-mediated sympathoexcitation. Both EI- and EEapnea elicit marked increases in sympathetic outflow, albeit through
different mechanisms. Voluntary EI-apnea increases MSNA through a
variety of factors including unloading of the baroreceptors, chemoreflex activation, and an increased central drive-to-breathe (12, 17, 37,
38). On the other hand, EE-apnea increases MSNA predominantly
through chemoreflex stimulation, as well as a lack of ventilatory
restraint on sympathetic outflow, and increased central drive-tobreathe (17, 37, 38).
Experimental measures. Sympathetic neural recordings were obtained in the right peroneal nerve by microneurography, using standard procedures originally defined by Hagbarth and Vallbo (16) and
used frequently in our hands (2, 31, 39) (662C-3; Bioengineering of
University of Iowa, Iowa City, IA). Blood pressure was obtained
throughout the experimental protocol using finger photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The Netherlands), which was calibrated to manual sphygmomanometry. Heart
rate (HR) was calculated from a standard three-lead electrocardiogram. Stroke volume (SV) and cardiac output (CO) were acquired
using the Finometer Modelflow algorithm, and total peripheral resistance (TPR) was calculated as the quotient of mean arterial pressure
(MAP) and CO. All data were collected and analyzed offline using
LabChart6 and PowerLab (ADInstruments, Colorado Springs, CO).
Data analysis. For both the EI- and EE-apnea protocols, data were
analyzed for the 1-min baseline period and during the second half of
maximal voluntary apnea. MSNA was analyzed from the integrated
neurogram and from our technique to detect and extract action
potentials (APs) from the filtered raw MSNA signal (30). Integrated
MSNA was quantified using burst frequency and burst incidence
[bursts per minute and bursts per 100 heart beats (hb), respectively].
Furthermore, burst amplitude (normalized to the largest burst at
baseline, which was given a value of 100) and total MSNA (product
of normalized burst amplitude and burst frequency) were determined.
Individual APs were extracted from the filtered raw MSNA signal
using wavelet-based methodology, as first reported by others (6, 8),
and modified in our hands (30). Our approach, described in detail
elsewhere (2, 30), uses a continuous wavelet transform constructed
from real postganglionic sympathetic APs (30), that extracts APs at
their point of occurrence, and classifies them according to their
peak-to-peak amplitude into clusters (i.e., bins) of similarly-sized APs
using Scott’s rule (34). To enable investigation into whether recruitment of new, larger AP clusters occurred during apnea, a secondary
analysis stage was introduced whereby cluster characteristics were
manipulated within each participant so that minimum bin width,
maximum bin center, and the total number of bins would be identical
across conditions. Therefore, corresponding clusters at baseline and
apnea contain APs with similar peak-to-peak amplitudes, while additional clusters during apnea represent recruitment of latent subpopulations of larger-sized axons (i.e., not present at baseline).
AP variables were quantified using AP frequency and AP incidence
(APs per minute and APs per 100 hb, respectively), as well as the
mean AP content per integrated sympathetic burst. Furthermore, the
number of total AP clusters and the number of active clusters per burst
are presented. AP cluster latency was calculated as the average latency
of all APs present within that cluster (as measured by the time delay
between the R-wave of the electrocardiogram of the preceding cardiac
cycle and the negative peak of the AP waveform). To adjust for the
impact of interindividual variations in total cluster number on calculations of changes in AP cluster latency, the number of total clusters
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Table 2. Hemodynamic responses to end-inspiratory and
end-expiratory apnea
End-inspiratory apnea
⌬ MAP, mmHg
⌬ HR, beats/min
⌬ SV, ml
⌬ CO, l/min
⌬ TPR, mmHg·l⫺1·min
End-expiratory apnea
⌬ MAP, mmHg
⌬ HR, beats/min
⌬ SV, ml
⌬ CO, l/min
⌬ TPR, mmHg·l⫺1·min

YH

OH

CAD

9⫾5
2⫾9
⫺20 ⫾ 13
⫺1.1 ⫾ 1.0
5⫾3

6⫾8
3 ⫾ 10
⫺22 ⫾ 12
⫺1.2 ⫾ 0.9
7⫾5

8⫾8
2⫾4
⫺17 ⫾ 17
⫺1.0 ⫾ 0.9
5⫾3

11 ⫾ 4
4 ⫾ 11
⫺4 ⫾ 10
0.1 ⫾ 0.5
2⫾2

8⫾6
0⫾9
⫺12 ⫾ 8
⫺0.6 ⫾ 0.6
5⫾4

7⫾5
0⫾3
⫺7 ⫾ 10
⫺0.5 ⫾ 0.5
3⫾2

Values are mean ⫾ SD. YH, young healthy; OH, older healthy; CAD,
coronary artery disease; MAP, mean arterial pressure; HR, heart rate; SV,
stroke volume; CO, cardiac output; TPR, total peripheral resistance.

was normalized to 10 bins (i.e., 10% ranges of the largest detected
cluster, which was given a value of 100%) for this analysis step, as
described previously (2).
Statistical analysis. Mixed model ANOVAs (SigmaPlot 12.0; Systat Software, San Jose, CA) assessed the effect of group vs. time
(baseline vs. EI-apnea; baseline vs. EE-apnea) on MSNA and hemodynamic variables. Bonferroni-corrected post hoc procedures were
used to evaluate specific differences between means. Regression
analyses were used to determine specific relationships between variables when applicable. For the EE-apnea protocol, six participants
(YH, n ⫽ 2; OH, n ⫽ 2; CAD, n ⫽ 2) were excluded as their MSNA
signal was obscured by motor-unit activation and/or a signal-to-noise
ratio (SNR) that was too poor to allow for adequate AP analysis.
Statistical significance was set at P ⬍ 0.05, and all data are means ⫾
SD, unless otherwise stated.
RESULTS

As noted above, some MSNA recordings lacked appropriate
SNR or were contaminated by motor-unit activation. Also,
variations exist between individuals in the duration of apnea, as
well as within individuals in terms of the response and duration
to repeated apneas. To address these issues, Bland-Altman
analyses assessed the agreement between the first and second
EI- and EE-apneas for all MSNA and AP variables. Participants with SNR ⬎3.7 (i.e., to allow for adequate AP detection)
for both apneas were included in the analysis (EI-apnea, n ⫽
33; EE-apnea, n ⫽ 21). Briefly, while the second EI- and
EE-apnea were of longer duration (EI-apnea: 41 ⫾ 17 vs.
36 ⫾ 17 s; EE-apnea: 21 ⫾ 10 vs. 19 ⫾ 10 s; both P ⬍
0.05), no differences existed between the first and second
sympathetic response to either EI- or EE-apnea (all P ⫽
NS), and all MSNA and AP variables were without significant fixed or proportional bias (EI-apnea: total MSNA,
127 ⫾ 139, mean difference ⫾ SE; APs/burst, 0.6 ⫾ 0.5;
clusters/burst, 0.1 ⫾ 0.1; total clusters, 0.2 ⫾ 0.5; EE-apnea:
total MSNA, ⫺474 ⫾ 315; APs/burst, 0.6 ⫾ 0.7; clusters/
burst, 0.3 ⫾ 0.2; total clusters, ⫺0.5 ⫾ 0.6). With no
within-individual differences between the first and second

Table 3. Integrated MSNA and action potential indexes at
baseline and during maximal end-inspiratory apnea
Baseline
Integrated MSNA indexes
Burst frequency, bursts/min
YH
17 ⫾ 8
OH
35 ⫾ 9*
CAD
41 ⫾ 7*
Burst incidence, bursts/100 hb
YH
27 ⫾ 14
OH
60 ⫾ 14*
CAD
70 ⫾ 10*
Burst amplitude, AU
YH
57 ⫾ 8
OH
57 ⫾ 6
CAD
57 ⫾ 5
Total MSNA, AU
YH
908 ⫾ 389
OH
2,002 ⫾ 614*
CAD
2,357 ⫾ 415*
Action potential indexes
AP frequency, spikes/min
YH
189 ⫾ 222
OH
372 ⫾ 226
CAD
410 ⫾ 180
AP incidence, spikes/100 hb
YH
307 ⫾ 353
OH
614 ⫾ 343
CAD
694 ⫾ 302

EI-Apnea

⌬

41 ⫾ 8†
51 ⫾ 11†
53 ⫾ 8†

25 ⫾ 10
16 ⫾ 7‡
11 ⫾ 8‡

65 ⫾ 15†
82 ⫾ 13†
88 ⫾ 6†

38 ⫾ 18
22 ⫾ 14‡
18 ⫾ 10‡

100 ⫾ 25†
80 ⫾ 16†
69 ⫾ 13†

43 ⫾ 20
24 ⫾ 15‡
12 ⫾ 12‡

4,144 ⫾ 1379† 3,236 ⫾ 1476
4,077 ⫾ 1211† 2,075 ⫾ 1113‡
3,624 ⫾ 811† 1,267 ⫾ 700‡
691 ⫾ 480†
698 ⫾ 402†
584 ⫾ 279†

502 ⫾ 356
326 ⫾ 223
174 ⫾ 196‡

1,081 ⫾ 757†
1,136 ⫾ 681†
968 ⫾ 465†

774 ⫾ 581
522 ⫾ 461
274 ⫾ 305‡

Values are mean ⫾ SD. EI, end-inspiratory; MSNA, muscle sympathetic
nerve activity; YH, young healthy; OH, older healthy; CAD, coronary
artery disease; hb, heart beats; AU, arbitrary units; AP, action potential.
*Significantly different from YH baseline value, P ⬍ 0.01; †Significantly
different from baseline, P ⬍ 0.01; ‡Significantly different from YH delta
value, P ⬍ 0.01.

apnea, the average of the two EI- and two EE-apneas were
used in the final analysis. Reexamination of results with
removal of statistical outliers (i.e., those individuals with
data points that were more than 1.5 interquartile ranges
below the first quartile or above the third quartile) did not
significantly alter the results; therefore, data from these
individuals were retained in the final analysis (40). Finally,
the mean SNR in the current study was 4.1 ⫾ 0.5, which is
expected to produce a correct detection rate of ⬎90% and a
false positive rate of ⬍3% (30).
Figure 1 displays representative recordings of the integrated
MSNA neurogram and detected APs from one YH individual,
one OH individual, and one CAD patient at baseline and during
EI-apnea and EE-apnea.
Baseline vs. end-inspiratory apnea. The duration of the
second half of EI-apnea was 46 ⫾ 17 s (range 27 to 78 s) in
YH, 35 ⫾ 15 s (range 15 to 70 s) in OH, and 28 ⫾ 6 s (range
19 to 44 s) in CAD patients. In a pointwise contrast, CAD
patients had a lower EI-apnea duration compared with YH
(P ⬍ 0.01). MAP, HR, and TPR exhibited effects of time,
whereby each increased during EI-apnea, while reductions in
SV and CO occurred (all P ⬍ 0.05; Table 2); however, no
group differences existed in the hemodynamic response to
EI-apnea (all P ⫽ NS).

Fig. 1. Representative recordings of the integrated muscle sympathetic nerve activity (MSNA) neurogram and detected action potentials (APs) from one young
healthy (YH) individual (A), one older healthy (OH) individual (B), and one coronary artery disease (CAD) patient (C) at baseline and during end-inspiratory
(EI) and end-expiratory (EE) apnea. HR, heart rate; MAP, mean arterial pressure; bpm, beats per minute.
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00334.2016 • www.ajpheart.org
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Fig. 2. Action potential (AP) content per
burst (A), total clusters (B), and active clusters per burst (C) in young healthy (YH),
older healthy (OH), and coronary artery disease (CAD) patients at baseline and during
end-inspiratory (EI) apnea (left panel; individual lines represent individual data). Right
panel represents the absolute delta change
from baseline to EI-apnea. *Significantly
different from baseline, P ⬍ 0.01. †Significantly different from YH, P ⬍ 0.01. ‡Significantly different from OH, P ⬍ 0.01.
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Table 3 outlines the integrated MSNA and AP indexes
during EI-apnea and their relative baseline values. Compared
with YH, baseline burst frequency and burst incidence were
higher in OH and CAD (all P ⬍ 0.01), but no differences were
observed between OH and CAD (P ⫽ NS). Compared with
baseline, all integrated MSNA variables increased during EIapnea in all groups (all P ⬍ 0.01). However, compared with
YH, the change in integrated MSNA was blunted in OH and
CAD (all P ⬍ 0.01), with no differences between OH and CAD
(P ⫽ NS). Whereas EI-apnea resulted in increased AP frequency and AP incidence in all groups (all P ⬍ 0.01), CAD
patients had a reduced ability to increase AP frequency and AP
incidence compared with YH (both P ⬍ 0.01). No differences
in the AP frequency and AP incidence response existed between YH and OH (P ⫽ NS) or OH and CAD (P ⫽ NS).
Compared with baseline, the mean AP content per burst
increased during EI-apnea in YH (11 ⫾ 8 to 17 ⫾ 11 APs/
burst; P ⬍ 0.01) and OH (10 ⫾ 5 to 13 ⫾ 7 APs/burst; P ⬍
0.01), while no change occurred in CAD patients (10 ⫾ 4 to
11 ⫾ 5 APs/burst; P ⫽ NS; Fig. 2A). The magnitude of
response was reduced in both OH and CAD compared with YH
(P ⬍ 0.01), and further reduced in CAD vs. OH (P ⬍ 0.01).
When APs were binned according to their peak-to-peak amplitude, the number of total clusters of APs increased in YH
(9 ⫾ 3 to 14 ⫾ 4 total clusters; P ⬍ 0.01) and OH (13 ⫾ 3 to
14 ⫾ 3 total clusters; P ⬍ 0.01) during EI-apnea, but not in
CAD patients (14 ⫾ 3 to 12 ⫾ 3 total clusters; P ⫽ NS; Fig.
2B). The ability to recruit new clusters of APs was diminished
in OH and CAD patients compared with YH (P ⬍ 0.01), and
further decreased in CAD vs. OH (P ⬍ 0.01). Finally, the
number of active clusters per burst increased during EI-apnea
in YH (4 ⫾ 2 to 6 ⫾ 2 clusters/burst; P ⬍ 0.01) and OH (5 ⫾
1 to 6 ⫾ 2 clusters/burst; P ⬍ 0.01), but not in CAD patients
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(5 ⫾ 1 to 5 ⫾ 1 clusters/burst; P ⫽ NS; Fig. 2C). The
magnitude of change was lower in OH and CAD compared
with YH (both P ⬍ 0.01), and further lowered in CAD
compared with OH (P ⬍ 0.01). When all subjects were pooled,
EI-apnea duration correlated poorly with the mean AP content
per burst response (r ⫽ 0.207; P ⫽ NS) and the active clusters
per burst response (r ⫽ 0.277; P ⫽ NS) to apnea. EI-apnea
duration correlated moderately well with the total clusters
response (r ⫽ 0.553; P ⬍ 0.01) to apnea; however, when
accounting for age and incidence of CAD, EI-apnea duration
no longer predicted the total clusters response to apnea
(P ⫽ NS).
In all groups, at baseline (YH: R2 ⫽ 0.93; OH: R2 ⫽ 0.90;
CAD: R2 ⫽ 0.77; all P ⬍ 0.01) and during EI-apnea (YH: R2 ⫽
0.97; OH: R2 ⫽ 0.94; CAD: R2 ⫽ 0.91; all P ⬍ 0.01), a pattern
emerged whereby AP cluster latency decreased as a function of
normalized cluster number (i.e., as peak-to-peak AP cluster
amplitude increased). The mean responses (Fig. 3) were fitted
using an exponential function model at baseline and during
EI-apnea. Interestingly, the cluster size-latency profile shifted
downward for every corresponding cluster during apnea in YH
(range ⫺8 to ⫺48 ms; mean ⫺28 ⫾ 15 ms; P ⬍ 0.01), OH
(range ⫺15 to ⫺38 ms; mean ⫺32 ⫾ 7 ms; P ⬍ 0.01), and
CAD patients (range ⫺5 to ⫺58 ms; mean ⫺21 ⫾ 17 ms; P ⬍
0.01). No differences were found in the magnitude of change
between groups (all P ⫽ NS).
Baseline vs. end-expiratory apnea. The duration of the
second half of EE-apnea was 20 ⫾ 10 s (range 12 to 47 s) in
YH, 22 ⫾ 11 s (range 8 to 45 s) in OH, and 16 ⫾ 5 s (range
10 to 27 s) in CAD patients. No differences in duration were
observed for EE-apnea between groups (P ⫽ NS). Both
MAP and TPR exhibited effects of time, whereby values
increased during EE-apnea; in contrast, reductions occurred

Fig. 3. Action potential (AP) cluster latency as a function of normalized cluster number (i.e., size) at baseline and during end-inspiratory (EI) apnea in young
healthy (YH; left panel), older healthy (OH; middle panel), and coronary artery disease patients (CAD; right panel).
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in SV and CO (all P ⬍ 0.05; Table 2). However, no group
differences existed in the hemodynamic response to EEapnea (all P ⫽ NS).
Table 4 outlines the integrated MSNA and AP indexes
during EE-apnea and their relative baseline values. Once again,
compared with YH, baseline burst frequency and burst incidence were higher in OH and CAD (all P ⬍ 0.01), but no
differences were observed between OH and CAD (P ⫽ NS).
Compared with baseline, all integrated MSNA variables increased during EE-apnea in all groups (all P ⬍ 0.01). However, compared with YH, the changes in burst frequency, burst
amplitude, and total MSNA were blunted in OH and CAD (all
P ⬍ 0.01), while the change in burst incidence was lower in
CAD vs. YH (P ⬍ 0.01). No differences were found between
OH and CAD for any integrated MSNA variable (all P ⫽ NS).
Additionally, compared with baseline, EE-apnea resulted in
increased AP frequency and AP incidence in all groups (P ⬍
0.05); however, CAD patients had a decreased ability to
increase AP frequency and AP incidence compared with YH
(P ⬍ 0.01), while no differences existed between OH and
CAD (P ⫽ NS).
Compared with baseline, the mean AP content per burst
increased in YH (11 ⫾ 6 to 20 ⫾ 9 APs/burst; P ⬍ 0.01) and
OH (11 ⫾ 4 to 15 ⫾ 8 APs/burst; P ⬍ 0.01) in response to
EE-apnea, but was unchanged in CAD patients (11 ⫾ 6 to
13 ⫾ 6 APs/burst; P ⫽ NS; Fig. 4A). The change in the mean
AP content per burst was lower in OH and CAD than in YH
(both P ⬍ 0.01); however, no difference existed between OH
and CAD (P ⫽ NS). When APs were binned according to their
peak-to-peak amplitude, the number of total clusters of APs
Table 4. Integrated MSNA and action potential indexes at
baseline and during maximal end-expiratory apnea
Baseline

EE-Apnea

⌬

Integrated MSNA indexes
Burst frequency, bursts/min
YH
19 ⫾ 7
42 ⫾ 12†
24 ⫾ 13
OH
33 ⫾ 9*
49 ⫾ 11†
16 ⫾ 6‡
CAD
41 ⫾ 8*
51 ⫾ 5†
10 ⫾ 7‡
Burst incidence, bursts/100 hb
YH
29 ⫾ 11
64 ⫾ 17†
34 ⫾ 20
OH
56 ⫾ 16*
83 ⫾ 13†
27 ⫾ 14
CAD
70 ⫾ 11*
89 ⫾ 5†
18 ⫾ 13‡
Burst amplitude, AU
YH
57 ⫾ 7
124 ⫾ 55†
67 ⫾ 51
OH
56 ⫾ 9
79 ⫾ 25†
22 ⫾ 22‡
CAD
58 ⫾ 5
81 ⫾ 19†
23 ⫾ 16‡
Total MSNA, AU
YH
1,006 ⫾ 381 5,147 ⫾ 2,379† 4,141 ⫾ 2,523
OH
1,839 ⫾ 557 3,793 ⫾ 1,170† 1,953 ⫾ 1,165‡
CAD
2,372 ⫾ 425* 4,103 ⫾ 996† 1,731 ⫾ 762‡
Action potential indexes
AP frequency, spikes/min
YH
216 ⫾ 207
852 ⫾ 491†
636 ⫾ 351
OH
370 ⫾ 191
731 ⫾ 430†
361 ⫾ 303
CAD
447 ⫾ 262
662 ⫾ 301†
215 ⫾ 155‡
AP incidence, spikes/100 hb
YH
347 ⫾ 340 1,278 ⫾ 669†
931 ⫾ 499
OH
609 ⫾ 298 1,219 ⫾ 738†
610 ⫾ 589
CAD
760 ⫾ 418 1,162 ⫾ 531†
402 ⫾ 312‡

Values are mean ⫾ SD. EE, end-expiratory; MSNA, muscle sympathetic
nerve activity; YH, young healthy; OH, older healthy; CAD, coronary artery
disease; hb, heart beats; AU, arbitrary units; AP, action potential. *Significantly different from YH baseline value, P ⬍ 0.01; †Significantly different
from baseline, P ⬍ 0.01; ‡Significantly different from YH delta value, P ⬍
0.01.

increased in YH (8 ⫾ 4 to 14 ⫾ 5 total clusters; P ⬍ 0.01), but
was unchanged in both OH (12 ⫾ 3 to 13 ⫾ 4 total clusters;
P ⫽ NS) and CAD patients (13 ⫾ 4 to 12 ⫾ 2 total clusters;
P ⫽ NS; Fig. 4B). As such, the ability to recruit new clusters of
APs was diminished in OH and CAD compared with YH (both
P ⬍ 0.01). Finally, compared with baseline, the number of active
clusters per burst increased during EE-apnea in YH (4 ⫾ 2 to 6 ⫾
2 clusters/burst; P ⬍ 0.01) and OH (5 ⫾ 1 to 6 ⫾ 2 clusters/burst;
P ⬍ 0.01), but not in CAD patients (5 ⫾ 1 to 6 ⫾ 1 clusters/burst;
P ⫽ NS; Fig. 4C). The magnitude of change was lower in OH and
CAD compared with YH (P ⬍ 0.01). When all subjects were
pooled, EE-apnea duration correlated poorly with the mean AP
content per burst response (r ⫽ 0.029; P ⫽ NS), the active clusters
per burst response (r ⫽ 0.117; P ⫽ NS), as well as the total
clusters response (r ⫽ 0.297; P ⫽ NS) to apnea.
Similar to EI-apnea, a pattern emerged during baseline (YH:
R2 ⫽ 0.76; OH: R2 ⫽ 0.85; CAD: R2 ⫽ 0.88; all P ⬍ 0.01) and
EE-apnea (YH: R2 ⫽ 0.95; OH: R2 ⫽ 0.97; CAD: R2 ⫽ 0.87;
all P ⬍ 0.01), whereby AP cluster latency decreased as a
function of normalized cluster number (i.e., as peak-to-peak
AP cluster amplitude increased). The mean responses (Fig. 5)
were fitted using an exponential function model at baseline and
during EE-apnea. Once again, the cluster size-latency profile
shifted downward for every corresponding cluster during apnea
in YH (range ⫺12 to ⫺74 ms; mean ⫺35 ⫾ 23 ms; P ⬍ 0.01),
OH (range 0 to ⫺47 ms; mean ⫺30 ⫾ 14 ms; P ⬍ 0.01), and
CAD patients (range ⫺31 to ⫺87 ms; mean: ⫺59 ⫾ 17 ms;
P ⬍ 0.01). No differences were found in the magnitude of
change between groups (all P ⫽ NS).
DISCUSSION

The novel findings of the current work are 1) compared with
young individuals, the ability to increase within-burst firing
frequency of already-recruited sympathetic fibers was reduced
with aging and CAD; 2) the capacity of the sympathetic
nervous system to recruit subpopulations of previously silent
and faster conducting fibers was reduced with aging and lost in
CAD; and 3) the ability to acutely modify synaptic delays
and/or central processing times appears preserved with aging
and CAD. Taken together, this work supports the hypothesis
that cardiovascular disease impairs sympathetic recruitment
during apneic stress.
Voluntary apnea represents a robust stimulus for efferent
sympathetic outflow through various mechanisms including
hypoxia and hypercapnia-induced chemoreceptor activation,
removal of the inhibitory influence of lung-stretch receptors,
and an increased central drive-to-breathe (17, 37, 38). Early
work from single-unit recordings demonstrated that the homeostatic adjustment to apnea involves an increased neural firing
frequency and probability, as well as an increase in the incidence of multiple within-burst firing of single axons (22). Our
previous work (2, 5, 39), and the results from the current study
using a multiunit approach, are in agreement with this finding,
at least in YH individuals. Although both OH individuals and
CAD patients achieved an elevation in total sympathetic outflow through increased frequency and incidence of AP firing
during apnea, the ability to increase the number of APs per
sympathetic burst was reduced with healthy aging and lost in
CAD patients. Therefore, the impact of CAD appears to be
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Fig. 4. Action potential (AP) content per
burst (A), total clusters (B), and active clusters per burst (C) in young healthy (YH),
older healthy (OH), and coronary artery disease (CAD) patients at baseline and during
end-expiratory (EE) apnea (left panel; individual lines represent individual data). Right
panel represents the absolute delta change
from baseline to EE-apnea. *Significantly
different from baseline, P ⬍ 0.01. †Significantly different from YH, P ⬍ 0.01.
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Fig. 5. Action potential (AP) cluster latency as a function of normalized cluster number (i.e., size) at baseline and during end-expiratory (EE) apnea in young
healthy (YH; left panel), older healthy (OH; middle panel), and coronary artery disease patients (CAD; right panel).

additive to normal age-related changes in central autonomic
integration.
Previously, we observed recruitment of latent subpopulations of larger and faster conducting sympathetic axons during
periods of severe autonomic stress, elicited via voluntary apnea
(2, 5, 39) and by ⫺80 mmHg lower-body negative pressure (2,
31). However, the current work extends this knowledge to
pathological states with known sympathetic dysregulation. In
accordance with previous work (24, 25), we show here that
older individuals have a reduced capacity to recruit these latent
neural subpopulations compared with their young counterparts,
while the ability to do so is further reduced and perhaps lost
altogether in CAD. The mechanism of this dysregulation is
unknown. One possibility is that the elevation in efferent
sympathetic outflow at rest observed with healthy aging and
cardiovascular disease is, in part, mediated by the additional
recruitment of these latent subpopulations, thereby reducing
the residual capacity for further recruitment during acute physiological stress. However, the capacity for neural recruitment
was not hindered in otherwise healthy, younger subjects with
high baseline MSNA (⬃75 bursts/100 hb) (22), discounting the
possibility that a ceiling effect impairs the ability to observe
normal recruitment patterns. Furthermore, if these larger axons
were already recruited at rest, one may presume that older
individuals and CAD patients would have greater AP content
per sympathetic burst during baseline resting conditions; however, this was not the case in our study. These observations
point to abnormal central features of neural recruitment with
healthy aging and perhaps more so with cardiovascular disease,
rather than a loss of sympathetic reserve due to elevated resting
sympathetic outflow.
Synaptic delay variations and/or altered central processing
times appear to exist as a third recruitment strategy used by the

sympathetic nervous system to modify efferent sympathetic
outflow in the face of physiological challenge (2, 32). The
current observations replicate earlier observations (2), in that
voluntary apnea caused an acute downward shift in the AP
cluster size-latency relationship in YH individuals, such that all
APs with similar peak-to-peak amplitudes were recruited with
a shorter latency during the reflex-mediated stress. Previous
reports indicate that single axons display large latency variations at rest (23), and that reflex latency can change acutely
with stress (7, 11). The multiunit approach used here suggests
that a systemic and coordinated change in synaptic delay can
occur as well. Interestingly, this systemic downward shift in
the AP cluster size-latency profile with apnea was preserved
with aging, as well as CAD, suggesting that, in contrast to
actual recruitment, the option for synaptic delay variations is
preserved in these individuals. The location(s) or source of the
change in synaptic delay during apnea-induced stress remains
unknown, but may be due to the direct activation of the rostral
ventrolateral medulla from the nucleus tractus solitarius (20)
specific to chemoreceptor activation, and/or the presence of
faster conduction velocities within spinal descending pathways
specific to chemoreceptor stimulation (⬃5.5 m/s) vs. baroreceptor activation (⬃3.3 m/s) (19).
Methodological considerations. Whether the recruitment
impairment in OH individuals and CAD patients was due to a
smaller reflex stimulus, or to the pathology, cannot be determined specifically from the current analysis. In the context of
stimulus strength, variations in the apnea stimulus may have
influenced the between-group variations reported in the current
study. As mentioned above, the determinants of the apnea
autonomic response are not certain and may include the magnitude of chemoreflex stress, loss of lung-stretch afferent
activity, or an emotional drive to breathe (17, 37, 38), and
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various factors influence the breakpoint for voluntary apnea
(28). In this context, lack of arterial blood gas measures
represents a potential limitation of the current study. Although
the apnea duration varied within and among groups, they were
each of maximal voluntary duration and elicited near-maximal
levels of burst probability; therefore, these represent maximal
sympathetic efforts. Furthermore, in the current study, EI- and
EE-apnea duration correlated poorly with indexes of AP recruitment. While apnea duration related significantly to the
total clusters response (r ⫽ 0.554) to EI-apnea (but not EEapnea; r ⫽ 0.297), this was no longer the case when the effects
of age and CAD were accounted for. Therefore, at least in our
data set, variations in apnea duration are an unlikely determinant of the current observations.
Second, as is commonly practiced (21, 24, 26), CAD patients were studied during their standard pharmacological treatment, and no data exist regarding the effect of medications on
sympathetic neural recruitment strategies. However, medication use is a “life-long” therapy for CAD patients, increasing
the relevance of studying these participants in the pharmacologically treated state. In addition, all OH individuals studied
currently were unmedicated and still displayed impaired central recruitment. If the pharmacological treatment in CAD was
causing the further detriment in recruitment observed in CAD
vs. OH during EI-apnea, one would expect the same further
detriment in recruitment during EE-apnea; however, this was
not the case. Taken together, these observations provide evidence to the fact that antihypertensive medications are unlikely
to be playing a role in our observed findings.
Furthermore, CAD patients had greater body mass index
(BMI) than their YH and OH counterparts, and increased BMI
has been known to alter baseline integrated MSNA (33).
Whether elevated BMI affects AP recruitment patterns remains
unknown; however, in the current study, BMI correlated poorly
to all but one index of sympathetic recruitment, suggesting it
did not play a role in our observed findings. Nonetheless, when
all subjects were pooled, BMI was correlated moderately to the
total cluster response to EI- (r ⫽ 0.441, P ⫽ 0.003) and EE(r ⫽ 0.371, P ⫽ 0.026) apnea. However, when accounting for
age and incidence of CAD, BMI no longer predicted the total
cluster response to either apnea. In addition, these aberrant AP
recruitment patterns were observed within 2– 4 mo of the
coronary event, and their persistence will require additional
study.
Finally, we acknowledge that the use of only one sympathoexcitatory reflex limits the applicability of the apnea outcomes to other important reflexes, and therefore, future study
should assess responses to additional reflex stimuli (i.e., baroreflex, metaboreflex, cold pressor test, etc.) to determine if the
observed impairment in central recruitment with aging and
cardiovascular disease is specific to apneic stress or a generalized pattern across reflexes.
Summary. Autonomic nervous system dysregulation represents a hallmark of increasing age and cardiovascular disease.
Studied primarily under resting conditions, healthy aging and
cardiovascular disease are characterized by chronic sympathetic activation, and this state has deleterious consequences
for overall health and prognosis. For the first time, the current
data indicate that this sympathetic dysfunction extends to the
neural coding strategies used by the sympathetic nervous
system to respond to acute homeostatic challenge. Specifically,
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the sympathetic nervous system normally has options to increase the firing of already-recruited axons, recruit latent subpopulations of higher-threshold and faster conducting axons,
and modify acutely synaptic delays in response to autonomic
arousal. The ability to acutely modify synaptic delays and/or
central processing times appears preserved with aging and
CAD. However, the ability to increase firing frequency and
probability of low-threshold axons is reduced with healthy
aging and more so with CAD. Furthermore, the ability to
recruit previously silent subpopulations is reduced with increasing age and perhaps lost altogether with CAD. As such,
CAD augments the impact of age on recruitment strategies
employed by the sympathetic nervous system.
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